| scholarly article | Q13442814 |
| P2093 | author name string | Wang J | |
| Aime S | |||
| Raymond KN | |||
| Botta M | |||
| Barge A | |||
| Doble DM | |||
| P2860 | cites work | Structure of a further triterpene saponin fromArenaria filicaulisBoiss. | Q104667030 |
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | contrast agent | Q6849688 |
| P304 | page(s) | 10758-10759 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Journal of the American Chemical Society | Q898902 |
| P1476 | title | Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd(III) complexes | |
| P478 | volume | 123 |
| Q35458246 | A (Fluoroalkyl)Guanidine Modulates the Relaxivity of a Phosphonate-Containing T1-Shortening Contrast Agent |
| Q35486300 | A bidentate terephthalamide ligand, TAMmeg, as an entry into terephthalamide-containing therapeutic iron chelating agents |
| Q52682401 | Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications. |
| Q24594049 | Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity |
| Q34809764 | Coupling fast water exchange to slow molecular tumbling in Gd3+ chelates: why faster is not always better |
| Q28235682 | Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers |
| Q28283802 | Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers |
| Q30576125 | Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agent |
| Q43063011 | Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents. |
| Q35665118 | Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging |
| Q33463644 | Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents |
| Q30868530 | High relaxivity Mn(2+)-based MRI contrast agents. |
| Q60921505 | Influence of Molecular Mobility on Contrast Efficiency of Branched Polyethylene Glycol Contrast Agent |
| Q27000361 | Lanthanide probes for bioresponsive imaging |
| Q60319137 | Lanthanide-Based Conjugates as Polyvalent Probes for Biological Labeling |
| Q30616187 | Modulating water-exchange rates of lanthanide(III)-containing polyaminopolycarboxylate-type complexes using polyethylene glycol |
| Q57376627 | Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents |
| Q64252823 | Preparation and Properties of Tumor-Targeting MRI Contrast Agent Based on Linear Polylysine Derivatives |
| Q30660032 | Strategies for optimizing water-exchange rates of lanthanide-based contrast agents for magnetic resonance imaging |
| Q57391311 | Structure, Dynamics, and Computational Studies of Lanthanide-Based Contrast Agents |
| Q31062213 | Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules. |
| Q47602413 | Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer |
| Q57340454 | Synthesis and Characterization of Ligands and their Gadolinium(III) Complexes |
| Q33262326 | Synthesis and characterization of a novel paramagnetic macromolecular complex [Gd(TTDASQ-protamine)]. |
| Q45814502 | Synthesis and relaxivity studies of a DOTA-based nanomolecular chelator assembly supported by an icosahedral closo-B₁₂²⁻ core for MRI: a click chemistry approach. |
| Q33649688 | Toward the Design of MR Agents for Imaging β-Cell Function. |
Search more.